1 / 7

U.S. General Anesthesia Drugs Market Worth $2 Billion by 2020

The U.S. General Anesthesia Drugs Market is expected to reach around $2 Billion by 2020 at a CAGR of 3.8% from 2015 to 2020.

jessicakellymnm1234
Download Presentation

U.S. General Anesthesia Drugs Market Worth $2 Billion by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. General Anesthesia Drugs Market Worth $2 Billion by 2020 www.MarketsandMarkets.com

  2. According to a new market research report "U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020",published by MarketsandMarkets, The U.S. General Anesthesia Drugs Market is expected to reach around $2 Billionby 2020 at a CAGR of 3.8% from 2015 to 2020. www.MarketsandMarkets.com

  3. Browse 42 market data Tables and 28 Figures spread through 114 Pages and in-depth TOC on "U.S. General Anesthesia Drugs Market“ http://www.marketsandmarkets.com/Market-Reports/anesthesia-drugs-ketamine-market-713.html Early buyers will receive 10% customization on this report. The U.S. general anesthesia drugs market is poised to reach ~ USD 2.0 billion by 2020 from USD 1.6 billion in 2015, at a CAGR of 3.8% from 2015 to 2020. Factors such as rapid rise in aging population, rising prevalence of cardiovascular and respiratory system-related diseases, and rising number of emergency surgeries are driving the growth of the U.S. general anesthesia drugs market. However, side effects associated with ketamine usage (such as elevation in blood pressure and heart rate, amnesia, respiratory depression, and hallucinations), regulatory issues, and lower compliance rates in comparison with other anesthetic drugs are likely to restrain the growth of this market.

  4. The market is segmented on the basis of molecule and route of administration. On the basis of molecules, the market is divided into Propofol, Benzodiazepine, Ketamine (S-(+)-Ketamine HCL), and Methohexital Sodium. Propofol is expected to be fastest-growing segment, owing to its greater preference and rapid onset of action. On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the U.S. general anesthesia drugs market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of this market. A complete brochure for this research is available @ http://www.marketsandmarkets.com/pdfdownload.asp?id=713 www.MarketsandMarkets.com

  5. Market Segmentation • The report segments the U.S. general anesthesia drugs market into the following segments: • By Route of Administration • Intravenous • Inhalational • By Molecule • Propofol • Benzodiazepine (Midazolam and Diazepam) • Ketamine (Esketamine hydrochloride or S-(+)-Ketamine hydrochloride) • Methohexital Sodium • Major players operating in the U.S. General Anesthesia Drugs Market are AstraZeneca plc (U.K.), Baxter International Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Mylan N.V. (U.S.), Eisai Co., Ltd. (Japan), Fresenius Se & Co. KGaA (Germany), Hospira, Inc. (U.S.), and Par Pharmaceutical Companies, Inc. (U.S.). www.MarketsandMarkets.com

  6. BrowseRelatedReports: Operating Room Management Market by Product (Data Management, Anesthesia, Surgical, Performance), Application (Perioperative, Preoperative, OR Scheduling), Component (Software, Services), Delivery Mode (Web-Based, On-Premise) Global Forecast to 2019 http://www.marketsandmarkets.com/Market-Reports/operating-room-management-market-175407912.htm www.MarketsandMarkets.com

  7. About Report Publisher: • MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. • Annual Market Research Reports Subscription -http://www.marketsandmarkets.com/Subscription.html • Contact: • Mr. Rohan • Markets and Markets • UNIT no 802, Tower no. 7, SEZ • Magarpatta city, Hadapsar • Pune, Maharashtra 411013, India • 1-888-600-6441 www.MarketsandMarkets.com

More Related